Selected startups receive a wide range of resources, including seed funding, access to Illumina's sequencing platforms, laboratory space, and business development support. Participants also benefit from a robust network of mentors, industry experts, and potential investors. This comprehensive support system is designed to help startups overcome challenges and accelerate their growth in the competitive field of cancer research.
